Depnox SR Tablet (Sustained Release) 150 mg (HCL), also known as Wellbutrin, is an atypical antidepressant used to treat major depression, seasonal affective disorder, and to help people stop smoking. It works by increasing certain types of brain activity that stimulate and regulate mood.
Bupropion HCL is used to treat Major Depressive Disorder, avoid smoking cessation, and dysthymia (a depression disorder).
| Brand Name | Depnox SR |
|---|---|
| Type | Tablet (Sustained Release) |
| Weight | 150 mg |
| Generic | Bupropion Hydrochloride |
| Manufacturer | Jayson Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Bupropion works by inhibiting the reuptake of dopamine and norepinephrine at the pre-synaptic neuron, increasing synaptic levels of dopamine and norepinephrine in the nucleus accumbens and frontal cortex. Bupropion also affects GABA by modulating ion channels and stimulating the release of these neurotransmitters.
The length of time it takes for Bupropion to work depends on the individual. Generally, people begin to feel the effects of Bupropion within one to two weeks. Maximum effects may be seen two to four weeks after starting treatment.
Bupropion is rapidly and extensively absorbed with oral administration. The absorption of Bupropion is not affected by food.
Bupropion is primarily eliminated by metabolites excreted in the urine.
The recommended dose for adults is 150-300mg/day in divided doses. The dose should not exceed 450mg/day. The dose may be increased at intervals of three days, not to exceed 150mg/day at any one time.
Bupropion may be taken with or without food. It should be swallowed whole, not crushed or chewed. Tablets should not be split.
Common side effects include: dry mouth, difficulty sleeping, headaches, nausea and constipation. Serious side effects include seizures, thoughts of suicide, changes in heart rate, and/or shortness of breath.
Bupropion is generally considered to have low toxicity, although there is a risk of overdose if multiple doses are taken. If an overdose is suspected, seek medical attention immediately.
Patients should be advised of the risk of seizures, as well as the risk of new or worsening psychological symptoms. Bupropion can cause severe liver damage, and should not be taken by patients with liver problems.
Bupropion may interact with certain drugs, including monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), or tricyclic antidepressants (TCAs). Other drugs that may interact include diuretics, lithium, and antipsychotics.
Bupropion should not be taken by patients with tri-iodothyronine (T3) deficiency, seizure disorder, anorexia or bulimia, liver or kidney disease, or bipolar disorder.
Certain drugs may interact with Bupropion, including monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), or tricyclic antidepressants (TCAs). Other drugs that may interact include diuretics, lithium, and antipsychotics.
Bupropion should be taken with food to avoid stomach upset. Grapefruit or grapefruit juice may increase the amount of the drug in the body, so it is important to avoid grapefruit while taking medication.
It is not recommended to take Bupropion during pregnancy due to possible side effects on the fetus. Patients should consult a doctor before taking this medication.
It is not recommended to take Bupropion while breastfeeding, as it is passed into breast milk and can affect the infant. Patients should consult a doctor before taking this medication.
Signs of Bupropion overdose include dizziness, confusion, blurred vision, seizures, coma, and death. If an overdose is suspected, seek medical attention immediately.
Bupropion should not be taken by those who have a seizure or anorexia/bulimia history, liver or kidney disease, or bipolar disorder.
Bupropion should be taken as directed by a doctor. Most patients begin with a dose of 150 mg/day, which can be increased at intervals of three days, not to exceed 450mg/day.
Bupropion tablets should be stored at room temperature, 25°C (77°F), away from light and moisture.
The volume of distribution for Bupropion is 8-11L/kg.
The half-life of Bupropion is 24 hours on average, and varies from person to person.
The clearance for Bupropion is approximately 1.2-1.6L/kg/hour.
See in details version Depnox SR Tablet (Sustained Release) 150 mg also Depnox SR Tablet (Sustained Release) 150 mg in bangla
Dr. Ummay Habiba Sumi
Skin, Hair Transplant, Sex Specialist & Cosmetic Surgeon
Dermatology Doctor in Dhaka